HFrEF - Heart Failure With Reduced Ejection Fraction
Cardiovascular·MeSH: Heart Failure
Prevalence
1800.0 / 100K
Incidence
300.0 / 100K/yr
3 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for HFrEF - Heart Failure With Reduced Ejection Fraction?
BioSniper tracks 3 drugs in development for HFrEF - Heart Failure With Reduced Ejection Fraction across 1 company.
How many clinical trials target HFrEF - Heart Failure With Reduced Ejection Fraction?
There are 1 clinical trial targeting HFrEF - Heart Failure With Reduced Ejection Fraction tracked by BioSniper.
What is the prevalence of HFrEF - Heart Failure With Reduced Ejection Fraction?
The estimated prevalence of HFrEF - Heart Failure With Reduced Ejection Fraction is approximately 1800.0 per 100,000 population.
Deep-dive into HFrEF - Heart Failure With Reduced Ejection Fraction
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis